Recovery ⏱ Half-life: ~1 hour

Teriparatide

Teriparatide (Forteo, PTH 1-34)

Buy at SourcePeptides →
Half-Life
~1 hour
Purity
Pharmaceutical grade
Mol. Weight
4,117.8 Da
Form
Solution in pre-filled injection pen

What is Teriparatide?

Teriparatide (Forteo) was the first bone anabolic agent approved for osteoporosis (2002), representing a paradigm shift from purely antiresorptive approaches. By stimulating osteoblasts to build new bone rather than simply slowing bone loss, it can restore bone architecture in ways that bisphosphonates cannot.

Dosage Information (Research Use)

20mcg SC once daily in the thigh or abdominal wall. Treatment duration: up to 2 years. Follow with antiresorptive therapy. Prescription medication.

Reconstitution & Handling

Pre-filled pen — no reconstitution.

Half-Life & Pharmacokinetics

~1 hour

Reported Observations in Literature

Leg cramps (3%), nausea (9%), headache (8%), dizziness (8%), orthostatic hypotension (5%), hypercalcemia (11% mild). Black box warning for osteosarcoma (rodent data at 3-60x human doses). Contraindicated in Paget’s disease and prior bone radiation.

Key Research References

  • Neer RM et al. “Effect of parathyroid hormone (1-34) on fractures and bone mineral density.” N Engl J Med. 2001;344:1434-41

How Teriparatide Works

Teriparatide is recombinant human PTH (1-34), the biologically active N-terminal fragment. When administered intermittently (once daily), it paradoxically stimulates bone formation over resorption — a phenomenon called the "anabolic window." This occurs because osteoblasts respond to pulsatile PTH with increased activity, while continuous PTH exposure favors osteoclast activation and bone resorption.

Research Applications

🔬 Osteoporosis treatment
🔬 Bone fracture healing
🔬 Osteogenesis imperfecta

Research Findings

The pivotal fracture prevention trial showed 65% reduction in vertebral fractures and 53% reduction in nonvertebral fractures. Increases BMD by 9-13% at the lumbar spine over 18 months. Sequential therapy with antiresorptive agents after teriparatide is essential to maintain gains.

Dosage & Administration

20mcg SC once daily in the thigh or abdominal wall. Treatment duration: up to 2 years. Follow with antiresorptive therapy. Prescription medication.

Safety & Side Effects

Leg cramps (3%), nausea (9%), headache (8%), dizziness (8%), orthostatic hypotension (5%), hypercalcemia (11% mild). Black box warning for osteosarcoma (rodent data at 3-60x human doses). Contraindicated in Paget's disease and prior bone radiation.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Molecular Weight 4,117.8 Da
Half-Life ~1 hour
Purity Pharmaceutical grade
Form Solution in pre-filled injection pen
Storage Refrigerate 2-8°C.

Key Research References

  • Neer RM et al. "Effect of parathyroid hormone (1-34) on fractures and bone mineral density." N Engl J Med. 2001;344:1434-41

Get Teriparatide from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →

Related Peptides

View all →
Vilon
Recovery
Thymus-targeting dipeptide bioregulator researched for immune restoration and T-cell function support.
View Profile → Buy at SP →
Vesilute
Recovery
Bladder-targeting peptide bioregulator researched for urinary tract epithelial support and detrusor muscle function.
View Profile → Buy at SP →
Lanreotide
Recovery
Long-acting somatostatin analog for acromegaly and neuroendocrine tumors with convenient self-injectable depot formulation.
View Profile → Buy at SP →